Search Results - "Wright, Jon L"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Subtype selective NMDA receptor antagonists: evaluation of some novel alkynyl analogues by KORNBERG, Brian E, NIKAM, Sham S, WRIGHT, Jon L, KESTEN, Suzanne R, MELTZER, Leonard T, COUGHENOUR, Linda, BARR, Bridget, SERPA, Kevin A, MCCORMICK, Julie

    Published in Bioorganic & medicinal chemistry letters (08-03-2004)
    “…A benzylpiperidine analogue with an acetylenic linker, 5-(3-[4-(4-fluorobenzyl)-piperidin-1-yl]-prop-1-ynyl)-1,3-dihydrobenzimidazol-2-one (3), was identified…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Discovery of selective dopamine D4 receptor antagonists: 1-Aryloxy-3-(4-aryloxypiperidinyl)-2-propanols by Wright, Jon L., Gregory, Tracy F., Heffner, Thomas G., MacKenzie, Robert G., Pugsley, Thomas A., Meulen, Seth Vander, Wise, Lawrence D.

    Published in Bioorganic & medicinal chemistry letters (03-06-1997)
    “…High volume screening identified 3-(4-benzylpiperidinyl)-1-naphthoxy-2-propanol as a selective dopamine D4 receptor ligand. A systematic structure-activity…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Parallel synthesis of a series of subtype-selective NMDA receptor antagonists by GREGORY, T. F, WRIGHT, J. L, WISE, L. D, MELTZER, L. T, SERPA, K. A, KONKOY, C. S, WHITTEMORE, E. R, WOODWARD, R. M

    Published in Bioorganic & medicinal chemistry letters (20-03-2000)
    “…A series of 1-(heteroarylthioalkyl)-4-benzylpiperidines was rapidly synthesized through the use of parallel synthesis to investigate the binding affinity for…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Pharmacological Characterization of PD 152255, a Novel Dimeric Benzimidazole Dopamine D 3 Antagonist by Corbin, Ann E, Pugsley, Thomas A, Akunne, Hyacinth C, Whetzel, Steven Z, Zoski, Kim T, Georgic, Lynn M, Nelson, Carrie B, Wright, Jon L, Wise, Lawrence D, Heffner, Thomas G

    Published in Pharmacology, biochemistry and behavior (01-02-1998)
    “…152255 ( E-1, 1′-(2-butene-1,4-diyl)bis [2-[4-[3-(1-piperidinyl)propoxy]-phenyl]-1H-benzimidazole]) exhibited high affinity ( K i = 12.7 nM) for human dopamine…”
    Get full text
    Journal Article
  16. 16

    Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonist by CORBIN, A. E, PUGSLEY, T. A, AKUNNE, H. C, WHETZEL, S. Z, ZOSKI, K. T, GEORGIC, L. M, NELSON, C. B, WRIGHT, J. L, WISE, L. D, HEFFNER, T. G

    Published in Pharmacology, biochemistry and behavior (01-02-1998)
    “…152255 (E-1,1'-(2-butene-1,4-diyl)bis[2-[4-[3-(1-piperidinyl)propoxy]-phe nyl]-1H-benzimidazole]) exhibited high affinity (Ki = 12.7 nM) for human dopamine…”
    Get full text
    Journal Article
  17. 17
  18. 18